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A 4-year-old girl presented for evaluation of an increasing number of 
pigmented lesions on the face and trunk that first started to appear 
at age 6 months. Her medical history was remarkable for congenital 
macrocephaly for which a cranial MRI at age 9 months showed no 
abnormalities. She was otherwise healthy with age-appropriate de-
velopment. Family history was unremarkable. Physical examination 
revealed Fitzpatrick phototype III skin and multiple periorbital dark 
brown and black soft papules of 3-5 mm size along with multiple 
milia (Figure 1). Similar pigmented lesions were found on the upper 
trunk and abdomen (Figure 2). Dermoscopy findings are presented 
in Figure 3. Furthermore, she exhibited a high forehead with frontal 
bossing. A shave biopsy of one of the pigmented papules on the neck 
was performed (Figure 4).
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Diagnosis: Nevoid basal cell carcinoma syndrome 
(NBCCS), also known as Gorlin syndrome
Histopathological examination showed small nests and anastomo-
sing strands of basaloid cells in the dermis partially connected to 
the epidermis with peripheral palisading and clefting from surround-
ing stroma, consistent with basal cell carcinoma. Pigment was found 
both within the tumor cells and in melanophages (Figure 4). Genetic 
testing for PTCH1 was carried out and revealed the pathogenetic 
c.584G > A (p.(Arg195Lys) variant, which has been rarely described 
in NBCCS. The same mutation was detected in her mother, who also 
showed clinical characteristics of NBCCS. On clinical examination, 
numerous palmoplantar pits were found in our patient. Surveillance 
protocol for close monitoring of cutaneous and systemic manifesta-
tions of NBCCS was initiated.
DISCUSSION
NBCCS is a rare cancer-prone genetic disorder characterized by 
the development of multiple basal cell carcinomas (BCCs), odonto-
genic keratocysts of the jaw, palmar or plantar pits, calcification of 
the falx cerebri, and a high incidence of tumors, including childhood 
medulloblastoma, and ovarian and cardiac fibromas.1 It is caused by 
germ line mutations in PTCH1, PTCH2, and SUFU, involved in Sonic 
Hedgehog signaling.2 The disorder is inherited in an autosomal domi-
nant fashion with almost complete penetrance and variable expres-
sivity. Diagnosis of NBCCS is based on clinical criteria modified by 
Bree et al in 2013. Diagnosis may be delayed due to the late appear-
ance of many cardinal features, with a reported mean age at diag-
nosis of 25 years. Thus, molecular testing is encouraged in patients 
with possible NBCCS not fulfilling clinical criteria, as well as in first-
degree relatives of affected patients.
Proactive surveillance for systemic manifestations of GS includ-
ing yearly brain MRI examinations to exclude medulloblastoma until 
age 8 years, avoidance of radiation, and emphasis on timely adoption 
of sun-protective measures is of utmost importance to reduce overall 
morbidity. Hence, pediatricians and dermatologists should recognize 
early clinical signs of NBCCS. At birth, infants may display macro-
cephaly. Additional early distinctive features include frontal bossing, 
coarse facies, hypertelorism, and facial milia around the eyes or on 
the forehead. Although periorbital milia have been reported to occur 
in 30% of patients, they are a poorly recognized early cutaneous fea-
ture of NBCCS.3 In rare instances, affected individuals may develop 
cleft palate or cleft lip and eye abnormalities including congenital 
cataracts, orbital cysts, and microphthalmia.3,4 Acral pits are com-
monly found in patients with NBCCS, but are not usually evident 
until later childhood. However, in our experience, palmoplantar pits 
can be present in infants and at preschool age as a pathognomonic 
feature, but are easily overlooked. BCCs are the hallmark of NBCCS 
and their clinical presentation is variable. Predilection sites of BCCs, 
which evolve from childhood onwards, are the face, neck, and trunk, 
including nonsun-exposed areas such as the axilla.3 More recently, a 
striking phenotype of early onset of acral BCCs has been described 
in patients with GS.5,6 BCCs in GS are nevoid lesions appearing as 
flesh-colored or pigmented papules, pedunculated lesions, nodules, 
or plaques. They may be mistaken for common nevi, molluscum, and 
skin tags or acrochordons.7,8 The occurrence of these lesions in large 
numbers may also contribute to misdiagnosis. Indeed, our patient 
had a darker skin type and exhibited multiple pigmented BCCs that 
had been mistaken for melanocytic nevi. In such cases, dermoscopy 
may be a useful tool to achieve a correct diagnosis since no typical 
melanocytic structures are observed.8
Early nevoid BCCs in childhood usually do not behave aggres-
sively, so a watchful waiting strategy and avoidance of invasive pro-
cedures is considered a reasonable approach.5 Our patient's BCCs 
showed no evidence of invasive behavior over 4-year follow-up. 
Therefore, we opted for clinical follow-up and shave excision of the 
most aesthetically bothersome lesions on the face and trunk, with 
excellent result.
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